中播數據(00471.HK):調整可換股票據的轉換價
格隆匯10月10日丨中播數據(00471.HK)公佈,根據可換股票據之條款及條件,轉換價須因股份合併而作出調整。可換股票據的轉換價將於股份合併生效後予以調整。
茲通吿根據可換股票據之條款及條件,轉換價因股份合併而作出調整。轉換價(目前為每股現有股份0.35港元)將調整至每股合併股份7.00港元,自2024年10月10日起生效。經參考可換股票據於公吿日期之尚未償還本金總額12,000,000美元,按先前轉換價及經調整轉換價轉換所有尚未行使可換股票據後將予發行之最高股份數目將分別為266,742,857股現有股份及13,337,142股合併股份。
除上述調整外,尚未轉換可換股票據的所有其他條款及條件維持不變。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.